CN1178110A - Medicine for lung cancer - Google Patents
Medicine for lung cancer Download PDFInfo
- Publication number
- CN1178110A CN1178110A CN 96118359 CN96118359A CN1178110A CN 1178110 A CN1178110 A CN 1178110A CN 96118359 CN96118359 CN 96118359 CN 96118359 A CN96118359 A CN 96118359A CN 1178110 A CN1178110 A CN 1178110A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- lung cancer
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 28
- 201000005202 lung cancer Diseases 0.000 title claims abstract description 24
- 208000020816 lung neoplasm Diseases 0.000 title claims abstract description 24
- 229940079593 drug Drugs 0.000 title claims abstract description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 6
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 6
- 238000007670 refining Methods 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 3
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 3
- 241000959626 Calvatia Species 0.000 claims description 3
- 241000756943 Codonopsis Species 0.000 claims description 3
- 241000190633 Cordyceps Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 3
- 241001646826 Isodon rubescens Species 0.000 claims description 3
- 241000283956 Manis Species 0.000 claims description 3
- 241000237636 Pheretima Species 0.000 claims description 3
- 241001250596 Pleione Species 0.000 claims description 3
- 241000411851 herbal medicine Species 0.000 claims description 3
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 235000019640 taste Nutrition 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims 2
- 238000002156 mixing Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000489492 Arisaema Species 0.000 abstract 1
- 244000061508 Eriobotrya japonica Species 0.000 abstract 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000157511 Oldenlandia Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A series of medicines including oral medicine, refined oral medicine and exterior-used medicine for curing lung cancer is prepared from more than 50 Chinese-medicinal materials such as arisaema tuber, oldenlandia, loquat leaf, houttuynia, peach leaf, etc. and features notable curative effect and no toxic by-effect.
Description
Medicine for lung cancer of the present invention relates to the Chinese herbal and crude drugs preparations with the vegetable material preparation, is a kind of Chinese herbal medicine that is used for the treatment of pulmonary carcinoma.
As everyone knows, the sickness rate of pulmonary carcinoma is classified the first place as in all cancers, and cure rate then is a low level.Western medical treatment pulmonary carcinoma only limits to delay the development of disease, and a kind of control that disease is carried out temporarily is in case the disease burst is even use whole skills, also of no avail.Moreover doctor trained in Western medicine is also big to the side effect of human body, even disease is temporarily controlled, normal cell is then wrecked simultaneously in the right health, finally still is difficult to flee from misfortune.Because the toxin of cancer is anything but merely on " cancer " word, but be five lung six internal organs.
The present invention is intended to overcome the side effect that western medicine therapy produces the human normal cell, thereby provides a kind of safe and effective, and the Chinese herbal medicine that As the medicine took effect, the symptoms lessened reaches the purpose of effecting a radical cure pulmonary carcinoma.
Technical scheme of the present invention system adopts three kinds of medicaments to be finished: promptly adopt respectively No. 1, No. 2 and No. 3 medicine for lung cancer are a course of therapy medicament, wherein No. 1 oral medicine of medicine for lung cancer comprises following composition:
Rhizoma Arisaematis, Radix Saposhnikoviae, Radix Glycyrrhizae, Rhizoma Pinelliae Preparata, Folium Persicae, Fructus Trichosanthis, Bulbus Fritillariae Uninbracteatae, Semen Armeniacae Amarum, Radix Platycodonis, Pseudobulbus Cremastrae Seu Pleiones, Fructus Arctii, Flos Lonicerae, Indigo Naturalis, Herba Hedyotidis Diffusae, Caulis Spatholobi, the Radix Astragali, Radix Codonopsis, Rhizoma Smilacis Glabrae, the Rhizoma Atractylodis Macrocephalae, Pericarpium Citri Reticulatae, Radix Adenophorae (Radix Glehniae), Radix Ophiopogonis, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Radix Scrophulariae, Spica Prunellae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Herba Houttuyniae, Radix Sophorae Tonkinensis, Herba Solani Lyrati, Cortex Lycii, Rhizoma Imperatae, Cortex Moutan, Lasiosphaera Seu Calvatia, Radix Sophorae Flavescentis, Rhizoma Polygonati, Herba Taraxaci, Rhizoma Paridis, Herba Scutellariae Barbatae, Herba Salviae Chinensis, Rabdosia rubescens, Fructus Ligustri Lucidi, Semen Plantaginis, Folium Artemisiae Argyi, Radix Scutellariae.Can add the five tastes, Pheretima, Folium Eriobotryae after 15 days, and remove Herba Houttuyniae, Radix Sophorae Flavescentis, Radix Scutellariae, wherein No. 2 refining oral medicine of medicine for lung cancer comprise following composition: Rhizoma Saururi (Herba Saururi), Squama Manis, Radix Notoginseng, Cordyceps, Radix Panacis Quinquefolii, wherein No. 3 medicine for lung cancer application compress comprise following composition: Folium Eriobotryae, Radix Notoginseng, Folium Persicae, the Pseudobulbus Bletillae (Rhizoma Bletillae), pollen, Rhizoma Paridis, Fructus Gardeniae, Bulbus Lycoridis Radiatae, Plumbum preparatium, Borneolum Syntheticum.
The present invention below is described in detail in detail: the medicament that use each course of treatment is respectively three kinds of models: the prescription of each model medicament of following division:
1., No. 1 oral medicine of medicine for lung cancer:
Rhizoma Arisaematis 3-5g Fructus Arctii 5-6g
Radix Saposhnikoviae 4-6g Flos Lonicerae 9-11g
Radix Glycyrrhizae 6-8g Indigo Naturalis 4-6g
Rhizoma Pinelliae Preparata 4-6g Herba Hedyotidis Diffusae 9-11g
Folium Persicae 4-6g Caulis Spatholobi 9-11g
Fructus Trichosanthis 4-6g Radix Astragali 9-11g
Bulbus Fritillariae Uninbracteatae 4-6g Radix Codonopsis 9-11g
Semen Armeniacae Amarum 4-6g Rhizoma Smilacis Glabrae 14-16g
Radix Platycodonis 3-5g Rhizoma Atractylodis Macrocephalae 4-6g
Pseudobulbus Cremastrae Seu Pleiones 4-6g Pericarpium Citri Reticulatae 9-11g
Radix Adenophorae (Radix Glehniae) 4-6g Radix Sophorae Flavescentis 3-5g
Radix Ophiopogonis 4-6g Rhizoma Polygonati 9-11g
Radix Salviae Miltiorrhizae 5-7g Herba Taraxaci 9-11g
Radix Paeoniae Rubra 4-6g Rhizoma Paridis 1-3g
Radix Scrophulariae 9-11g Herba Scutellariae Barbatae 4-6g
Spica Prunellae 4-6g Herba Salviae Chinensis 9-11g
Pseudobulbus Bletillae (Rhizoma Bletillae) 9-11g Rabdosia rubescens 4-6g
Herba Houttuyniae 9-11g Fructus Ligustri Lucidi 4-6g
Radix Sophorae Tonkinensis 4-6g Semen Plantaginis 4-6g
Herba Solani Lyrati 9-11g Folium Artemisiae Argyi 4-6g
Cortex Lycii 4-6g Radix Scutellariae 4-6g
Rhizoma Imperatae 9-11g Cortex Moutan 4-6g
Lasiosphaera Seu Calvatia 4-6g
Add five tastes 4-6g after 15 days again, Pheretima 3-5g, Folium Eriobotryae 9-11g removes Herba Houttuyniae, Radix Sophorae Flavescentis and Radix Scutellariae.
2., No. 2 refining oral medicine of medicine for lung cancer:
Rhizoma Saururi (Herba Saururi) 4-6g Cordyceps 3-5g
Squama Manis 3-5g Radix Panacis Quinquefolii 3-5g
Radix Notoginseng 3-5g
3., the medicine for lung cancer 3 extra drug of topical application:
Folium Eriobotryae 28-32g Bulbus Lycoridis Radiatae 18-22g
Folium Persicae 28-32g Plumbum preparatium 3-7g
Pollen 18-22g Borneolum Syntheticum 3-7g
Rhizoma Paridis 4-6g Radix Notoginseng 8-12g
Fructus Gardeniae 13-17g Pseudobulbus Bletillae (Rhizoma Bletillae) 18-22g
The making of No. 1 oral medicine of above-mentioned medicine for lung cancer and No. 2 refining oral medicine of medicine for lung cancer is all made to dry to grind into powder.The making of the medicine for lung cancer 3 extra drug of topical application is ground into powder to dry earlier, and reuse Folium Artemisiae Argyi 18-22g fries in shallow oil the water mediation and makes.The person is not advisable with cold compress bitterly, and pain person is advisable with hot compress.Apply day and stop night, apply and stop day night, potion on the one spreads on chest.
Medicine for lung cancer of the present invention is evident in efficacy, does not have any secondary toxic action, and can get the effect of radical cure.
Claims (2)
1, medicine for lung cancer system is made by multiple Chinese herbal medicine, it is characterized in that the present invention gives complete by three kinds of dosage forms, be No. 1 oral medicine of medicine for lung cancer, No. 2 refining oral medicine of medicine for lung cancer, the medicine for lung cancer 3 extra drug of topical application, three kinds of dosage forms are all with pulverizing, blending preparation patent medicine, and their prescription is as follows respectively:
1. No. 1 oral medicine of medicine for lung cancer:
Rhizoma Arisaematis 3-5g Fructus Arctii 5-6g
Radix Saposhnikoviae 4-6g Flos Lonicerae 9-11g
Radix Glycyrrhizae 6-8g Indigo Naturalis 4-6g
Rhizoma Pinelliae Preparata 4-6g Herba Hedyotidis Diffusae 9-11g
Folium Persicae 4-6g Caulis Spatholobi 9-11g
Fructus Trichosanthis 4-6g Radix Astragali 9-11g
Bulbus Fritillariae Uninbracteatae 4-6g Radix Codonopsis 9-11g
Semen Armeniacae Amarum 4-6g Rhizoma Smilacis Glabrae 14-16g
Radix Platycodonis 3-5g Rhizoma Atractylodis Macrocephalae 4-6g
Pseudobulbus Cremastrae Seu Pleiones 4-6g Pericarpium Citri Reticulatae 9-11g
Radix Adenophorae (Radix Glehniae) 4-6g Radix Sophorae Flavescentis 3-5g
Radix Ophiopogonis 4-6g Rhizoma Polygonati 9-11g
Radix Salviae Miltiorrhizae 5-7g Herba Taraxaci 9-11g
Radix Paeoniae Rubra 4-6g Rhizoma Paridis 1-3g
Radix Scrophulariae 9-11g Herba Scutellariae Barbatae 4-6g
Spica Prunellae 4-6g Herba Salviae Chinensis 9-11g
Pseudobulbus Bletillae (Rhizoma Bletillae) 9-11g Rabdosia rubescens 4-6g
Herba Houttuyniae 9-11g Fructus Ligustri Lucidi 4-6g
Radix Sophorae Tonkinensis 4-6g Semen Plantaginis 4-6g
Herba Solani Lyrati 9-11g Folium Artemisiae Argyi 4-6g
Cortex Lycii 4-6g Radix Scutellariae 4-6g
Rhizoma Imperatae 9-11g Cortex Moutan 4-6g
Lasiosphaera Seu Calvatia 4-6g
2. No. 2 refining oral medicine of medicine for lung cancer:
Rhizoma Saururi (Herba Saururi) 4-6g Cordyceps 3-5g
Squama Manis 3-5g Radix Panacis Quinquefolii 3-5g
Radix Notoginseng 3-5g
3. the medicine for lung cancer 3 extra drug of topical application:
Folium Eriobotryae 28-32g Bulbus Lycoridis Radiatae 18-22g
Folium Persicae 28-32g Plumbum preparatium 3-7g
Pollen 18-22g Borneolum Syntheticum 3-7g
Rhizoma Paridis 4-6g Radix Notoginseng 8-12g
Fructus Gardeniae 13-17g Pseudobulbus Bletillae (Rhizoma Bletillae) 18-22g
2, according to the described medicine for lung cancer of claim 1, it is characterized in that No. 1 oral medicine of medicine for lung cancer adds five tastes 4-6g again after using 15 days, Pheretima 3-5g, Folium Eriobotryae 9-11g removes Herba Houttuyniae, Radix Sophorae Flavescentis and Radix Scutellariae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96118359 CN1178110A (en) | 1996-09-28 | 1996-09-28 | Medicine for lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96118359 CN1178110A (en) | 1996-09-28 | 1996-09-28 | Medicine for lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1178110A true CN1178110A (en) | 1998-04-08 |
Family
ID=5125028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96118359 Pending CN1178110A (en) | 1996-09-28 | 1996-09-28 | Medicine for lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1178110A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074292C (en) * | 1999-05-19 | 2001-11-07 | 赵国民 | Cancer treating medicine capsule |
| CN1318073C (en) * | 2004-09-27 | 2007-05-30 | 上海市胸科医院 | Chinese medicine compound preparation for treating lung cancer |
| CN101085269B (en) * | 2007-06-08 | 2010-06-16 | 马海明 | Internal-applied traditional Chinese medicine composition for treating lung cancer |
| CN101152262B (en) * | 2007-09-25 | 2011-05-25 | 邱日辉 | New anti-gout medicinal preparation |
| CN103169746A (en) * | 2013-03-21 | 2013-06-26 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for treating lung cancer |
| CN103417872A (en) * | 2013-08-19 | 2013-12-04 | 王锦生 | TCM composition for treatment of lung cancer and preparation method thereof |
| CN103495025A (en) * | 2013-10-06 | 2014-01-08 | 张洪胜 | Traditional Chinese medicine preparation for treating pulmonary fibrosis |
-
1996
- 1996-09-28 CN CN 96118359 patent/CN1178110A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074292C (en) * | 1999-05-19 | 2001-11-07 | 赵国民 | Cancer treating medicine capsule |
| CN1318073C (en) * | 2004-09-27 | 2007-05-30 | 上海市胸科医院 | Chinese medicine compound preparation for treating lung cancer |
| CN101085269B (en) * | 2007-06-08 | 2010-06-16 | 马海明 | Internal-applied traditional Chinese medicine composition for treating lung cancer |
| CN101152262B (en) * | 2007-09-25 | 2011-05-25 | 邱日辉 | New anti-gout medicinal preparation |
| CN103169746A (en) * | 2013-03-21 | 2013-06-26 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for treating lung cancer |
| CN103417872A (en) * | 2013-08-19 | 2013-12-04 | 王锦生 | TCM composition for treatment of lung cancer and preparation method thereof |
| CN103495025A (en) * | 2013-10-06 | 2014-01-08 | 张洪胜 | Traditional Chinese medicine preparation for treating pulmonary fibrosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN1375298A (en) | Pain-relieving notoginseng mixture | |
| CN1100651A (en) | Chinese herbal prepn. for curing chronic gastroenteritis and peptic gastric ulcer | |
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN103230548A (en) | Traditional Chinese medicine composition for treating pulmonary heart disease | |
| CN101134085A (en) | Traditional Chinese medicine for treating apoplectic hemiplegia | |
| CN1840126A (en) | Chinese medicine for treating amblyopia and myopia | |
| CN102614442B (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN1178110A (en) | Medicine for lung cancer | |
| CN1539441A (en) | Compounded medicine for anti pathogeny and immunoenhancement | |
| CN101028481A (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
| CN101234189A (en) | A traditional Chinese medicine composition for preventing and treating cardiovascular inflammation (toxin) | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1160560A (en) | Chinese patent drug for curing leukopenia and its preparation process | |
| CN1357362A (en) | Jinyinxiaoshi powder | |
| CN1058911A (en) | The compound method of capsule for curing tumour | |
| CN1141114C (en) | Tendon-conditioning analgetic | |
| CN1217202A (en) | A medicine for treating rheumatic diseases | |
| CN1298724A (en) | Medicine for treating immunodefiiciency disease | |
| CN1181879C (en) | Analgestic plaster | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN1279943C (en) | Chinese medicine for treating brain disease | |
| CN100518800C (en) | Medicinal composition for treating hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |